29.10.2014 Views

MICARDIS MyCARD™ - Pharmacist eLink

MICARDIS MyCARD™ - Pharmacist eLink

MICARDIS MyCARD™ - Pharmacist eLink

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Pharmacist</strong>s can call 1-866-492-0053 for adjudication questions<br />

<strong>MICARDIS</strong> MyCARD <br />

Lower Your BP. Lower Your Cost.<br />

• Patients never pay more than $20 for<br />

a 30-day prescription of <strong>MICARDIS</strong> or<br />

<strong>MICARDIS</strong> HCT, whether paying with<br />

cash or using insurance<br />

• No forms, rebates, or coupons<br />

• Works at all retail pharmacies<br />

for 12 months<br />

• Program works regardless of<br />

insurance, excluding Medicare,<br />

Medicaid, and other federal- or state-funded programs<br />

• Patients are not eligible to participate in this program if they<br />

live in Massachusetts or in those states where prohibited by law<br />

<strong>MICARDIS</strong> and <strong>MICARDIS</strong> HCT are indicated for the treatment of hypertension.<br />

<strong>MICARDIS</strong> HCT is not indicated for initial therapy.<br />

<strong>MICARDIS</strong> and <strong>MICARDIS</strong> HCT are contraindicated in patients who are hypersensitive to any of<br />

their components. <strong>MICARDIS</strong> HCT is contraindicated in patients with anuria or hypersensitivity to<br />

other sulfonamide-derived drugs.<br />

USE IN PREGNANCY<br />

When used in pregnancy during the second and third trimesters, drugs that act directly<br />

on the renin-angiotensin system can cause injury and even death to the developing<br />

fetus. When pregnancy is detected, <strong>MICARDIS</strong> and <strong>MICARDIS</strong> HCT Tablets should be<br />

discontinued as soon as possible (see WARNINGS, Fetal/Neonatal Morbidity and Mortality).<br />

Thiazides cross the placental barrier and appear in cord blood. There is a risk of fetal or<br />

neonatal jaundice, thrombocytopenia, and possibly other adverse reactions that have occurred<br />

in adults.<br />

With <strong>MICARDIS</strong> monotherapy and other<br />

angiotensin II receptor blockers and ACE inhibitors<br />

in general, BP response in Blacks is noticeably<br />

less than in Caucasians.


<strong>Pharmacist</strong>s can call 1-866-492-0053 for adjudication questions<br />

As a pharmacist, what do I need to know?<br />

• Easy to process<br />

— Enter the patient’s primary<br />

insurance information as usual,<br />

and the <strong>MICARDIS</strong> MyCARD <br />

as a secondary benefit<br />

• Activation<br />

— This card will be ready to process<br />

15 minutes after activation<br />

• No installations<br />

RxBIN: 610524<br />

RxPCN: Loyalty<br />

RxGRP: 50775109<br />

ISSUER: (80840)<br />

ID: XXXXX<br />

Please see accompanying full Prescribing Information, including boxed WARNING, for <strong>MICARDIS</strong> and <strong>MICARDIS</strong> HCT.<br />

McKESSON<br />

— The <strong>MICARDIS</strong> MyCARD uses the NCPDP 5.1 transaction set for benefits<br />

coordination or primary claims<br />

• Unique revenue opportunity<br />

— You’ll collect a fee for every transaction<br />

• Reliable customer service<br />

— If you have any questions, you’ll receive prompt assistance by calling<br />

your dedicated <strong>MICARDIS</strong> MyCARD Customer Service Representative<br />

at 1-866-492-0053<br />

• Improved patient loyalty and adherence<br />

— Your patients may receive discounts and other services to educate them<br />

and motivate them to continue with their prescribed therapy<br />

• Protect your patients’ privacy<br />

— Your patients’information is always<br />

protected from unauthorized use<br />

and will never be shared<br />

Powered by:<br />

Before prescribing, please see accompanying full Prescribing Information, including boxed WARNING,<br />

for <strong>MICARDIS</strong> and <strong>MICARDIS</strong> HCT.<br />

Empowering Healthcare<br />

Copyright © 2006, Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. Printed in U.S.A. (08/06) MC12098E<br />

MC12098

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!